Summary: Substance concentrations of plasma Cholinesterase (EC 3.1.1.8) were measured in 94 healthy individuals without occupational exposure to known inhibitors (six samples from each individual). Immunoreactive Cholinesterase substance concentrations showed an inter-individual variation corresponding to CV total = 22% (mean: 5.01 mg/1, SD: 1.11 mg/1). Intra-individual variations of immunoreactive Cholinesterase substance concentration were correlated (r = 0.36) to intra-individual variations of albumin. Estimated by a repeated-measures analysis of variance, the observed intra-individual variation of Cholinesterase substance concentration corresponded to CV = 8.8% (SD: 0.44 mg/1), which together with a CV error = 6% (within and between runs), implies a biological intra-individual variation of Cholinesterase substance concentration corresponding to CV intra = 6.4%. Specific catalytic activity (kU/mg immunoreactive Cholinesterase) was influenced by the ChE-1 phenotype (phenotype U: 1.58 kU/mg, phenotype UA: 1.22 kU/mg), but not by body weight, height, age, and sex. Observed intra-individual variation of specific catalytic activity corresponded to 6.4% (SD: 0.10kU/mg), which together with an estimated CV error = 6.2% implies the biological intra-individual variations of specific catalytic Cholinesterase activity to be insignificant. The insignificant CV intra makes specific catalytic Cholinesterase activity a rational quantity for evaluation of unexpected fluctuations of Cholinesterase activity concentrations.
Introduction
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Imesterase activity concentration has been studied in Plasma Cholinesterase (pseudocholinesterase, buty-healthy individuals (5, 10 -14) and in patients with rylcholinesterase, acylcholine acylhydrolase, EC chronic liver diseases (10) . All studies demonstrate 3.1.1.8) occurs in blood plasma as a number of distinct substantial inter-individual variations, which are staisozymes, predominantly represented by a globular, tistically related to physiological factors such as body tetrameric (M r : 340 000) structure (1 -6) . Biosynthesis weight, height, and sex, but also influenced by a of the 574-amino-acid-subunit (7) is controlled by the variety of other physiological and pathological conChE-1 locus (8) . Recently (9) , the atypical, dibucaine ditions (for review, see I.e. (4)); inter-individual variresistant Cholinesterase isoform has been shown to be ations of Cholinesterase activity concentration are unan Asp-70 -> Gly mutation.
influenced by particular electrophoretic components (5) . Four of the studies (10, 11, 13, 14) demonstrate intra-individual variations in healthy individuals corresponding to a biological CV intra = 5 -5.5%; intra-') Cholinesterase, pseudocholinesterase, acylcholine acylhydro-individual variations of plasma Cholinesterase activity läse (EC 3.1.1.8).
. .
2 ) The study was financially supported by Aarhus University concentration are independent of age, body weight, Research Foundation. height, sex, or ChE-1 phenotype.
In health surveillance programmes, a decrease of plasma cholinesterase activity concentration in individuals who are occupationally exposed to organophosphorus pesticides, may readily be interpreted an indication of organophosphorus poisoning (15 Earlier studies indicate a close relation between cholinesterase activity concentration and cholinesterase substance concentration (16) . However, no systematic studies of normal inter-and intra-individual variations of cholinesterase substance concentration (mg/1) or specific cholinesterase activity (U/mg) have so far been published. The aim of the present study is to describe such inter-and intra-individual variations of immunoreactive plasma cholinesterase substance concentration and specific catalytic plasma cholinesterase activity in a healthy population group without occupational exposure to known cholinesterase inhibitors; further, the study analyses the relative influence of five factors (ChE-1 phenotype, sex, age, body weight, and height) on these variations; finally, the observed variations of cholinesterase substance concentration are compared with the accompanying variations of albumin concentration.
Materials and Methods

Samples
Consecutive values of immunoreactive plasma cholinesterase substance concentrations, plasma cholinesterase activity concentrations, and plasma albumin substance concentrations (six samples from each individual) were obtained from 94 (43 males, 51 females, aged 20 -65 years) of 193 apparently healthy individuals earlier studied (14) . Five of the 94 individuals were of ChE-1 phenotype = UA; the remaining 89 individuals were found to be of ChE-1 phenotype U.
Analytical methods
Immunoreactive cholinesterase substance concentrations were determined by an enzyme immunoassay (16) . Calibration was standardized with a highly purified human cholinesterase, which was quantitated according to Lowry et al. (17) . Albumin substance concentration was measured by a turbidimetric immunoassay using a polyclonal (rabbit) anti-human albumin (Q328, Dakopatts, Glostrup, Denmark). The calibration was standardized with a commercial protein standard (Human Serum Protein Calibrator, lot no. 048, Dakopatts, Glostrup, Denmark). Day to day reproducibility (Seronorm™ Human, batch no. 1200, Nycomed, Oslo, Norway): CV = 3.9% (x = 37.8 g/1, SD = 1.49 g/l, N = 86).
Statistics
Stepwise multiple regressions, analyses of variance, and repeated-measures analyses of variance were performed on an IBM PC/AT using the SPSS/PC + software package (SPSS Inc., Chicago, IL).
Results
Cholinesterase activity concentration and cholinesterase substance concentration The possible influence of sex, age, body weight, height, and ChE-1 phenotype on the inter-individual variation of cholinesterase substance concentration was analysed from a stepwise multiple regression (y = BO + BÄ + B 2 X 2 + + B n X n ; male = 1, female = 2, phenotype U = 1, phenotype UA = 2). Like catalytic cholinesterase activity concentrations (14) , immunoreactive cholinesterase substance concentrations are significantly influenced by body weight, height, sex, and ChE-1 phenotype (tab. 2). Of the five factors, only the ChE-1 phenotype (multiple r 2 = 0.739) influences the specific cholinesterase catalytic activity. Table 3 shows the relative influence by the four significant factors on the immunoreactive cholinesterase substance concentration as assessed from a two-way ANOVA. Of the 51 females, 7 used oral contraceptives; the 7 women taking contraceptive pills showed a significantly (0.01 < p < 0.05) lower unteers the difference between highest and lowest immunoreactive Cholinesterase substance concentration exceeded 30%. A quantitative estimate of the intra-individual variation was obtained from a repeated-measures analysis of variance. Table 4 shows an average intra-individual variation of immunoreactive Cholinesterase substance concentration corresponding to SD intra = 0.44 mg/1 (CV intra = 8.8%). Intra-individual variation of immunoreactive cholinesterase substance concentration was unrelated to sex or ChE-1 phenotype. The average intra-individual variation of catalytic Cholinesterase activity concentration (CV intra = 5.6%) was the same as previously reported (14) .
Intra-individual variations of specific catalytic cholinesterase activity were assessed from immunoreactive Cholinesterase substance concentrations and catalytic Cholinesterase activity concentrations. Standard deviations calculated from the six determinations in each individual varied from 0.03 to 0.21 kU/mg. Repeatedmeasures analysis of variance showed an average intra-individual variation corresponding to SD intra = 0.10 kU/mg (CV intra = 6.4%), without influence by sex or by ChE-1 phenotype.
Albumin concentration
Plasma albumin concentrations were found to be higher (p < 0.001) in the 43 males (x: 45.8 g/l; SD: 2.55 g/1) than in the 51 females (x: 42.7 g/l; SD: 2.84 g/1); further, a stepwise multiple regression analysis showed an influence by age (p < 0.001) and by body weight (0.01 < p < 0.05). Women who used oral contraceptives exhibited a significantly (p < 0.001) lower albumin concentration (x = 40.2 g/1, SD = 1.96 g/l, N = 7) than women who did not (x = 43.1 g/1, SD = 2.78 g/l, N = 44). Albumin concentrations were uncorrelated to Cholinesterase substance concentrations (r = 0.18).
Maximum intra-individual variations (differences between highest and lowest concentrations in percentage of a person's mean concentration) showed a distribution similar to that of Cholinesterase; mean: 16.7%; range: 4.3%-43%. Intra-individual variations of albumin concentration (expressed as CV) were correlated to intra-individual variations of Cholinesterase substance concentration (r = 0.36, p < 0.001).
Discussion
In earlier studies, the immunoreactive plasma Cholinesterase substance concentrations were reported to 5 -15 mg/1 (18 -21) . The present study shows a mean plasma immunoreactive Cholinesterase substance concentration of only 5 mg/1 (SD: 1.1 mg/1). Although there are various theoretical reasons for this discrepancy (for discussion, see I.e. (16)), the previously reported Cholinesterase substance concentrations were probably overestimated. This suggestion is supported by comparison of the Cholinesterase substance concentration (16) and protein concentration (17) in a highly purified Cholinesterase preparation (made by Dr. O. Lockridge, Univ. of Michigan, Ann Arbor, using affinity chromatography on procainamide sepharose (22) combined with ion exchange), which showed that the immunoreactive Cholinesterase substance concentration was 0.90 of that expected from the protein concentration.
Like Cholinesterase activity concentration, immunoreactive Cholinesterase substance concentration shows a substantial inter-individual variation. The same four factors that influence Cholinesterase activity concentration (sex, body weight, height, and ChE-1 phenotype) influence immunoreactive Cholinesterase substance concentration (tab. 3). Recently, body weight and height were also shown to influence alanine aminotransferase, aspartate aminotransferase, and γ-glutamyl transferase (23) . The mechanisms giving rise to lower immunoreactive Cholinesterase substance concentrations in individuals of ChE-1 phenotype UA than in matching individuals of ChE-1 phenotype U (tab. 2) are completely unknown (increased degradation?, decreased synthesis? decreased affinity of the monoclonal antibody to the UA isoform?). However, although mechanisms involved are unknown, the described effects have to be considered, when comparing unmatched population groups.
Individuals exhibiting large intra-individual variations of plasma cholinesterase substance concentration also tend to exhibit large intra-individual variations of albumin concentration. Roughly estimated, one seventh (0.36 2 ) of the observed intra-individual variance of cholinesterase substance concentration may be explained from this relationship (parallel fluctuations of cholinesterase and albumin synthesis/degradation?, variations due to preanalytical errors?). Suggesting simple additivity of variances, an average biological CV intra can be estimated from observed CV intra and CVe rr or· Even though intra-individual variations differ from one individual to another, such estimates are crucial in diagnostic decision-making (24) , and for defining appropriate analytical goals (25 -26) .
From the observed CV intra (8.8%) and the actual analytical imprecision (CV error = 6%), the biological CV intra for cholinesterase substance concentrations may be estimated to be 6.4%. In a similar way, the corresponding biological CV intra for cholinesterase activity concentration was calculated to be 5.4%; this estimate accords with other studies (10-11, 13 -14) and with results obtained from studies of other plasma enzymes (26) . From the actual CV error for catalytic cholinesterase activity concentration and immunoreactive cholinesterase substance concentration, the actual CV error of specific catalytic activity was calculated to be 6.2%. Combined with the observed CV intra (6.4%), this implies an insignificant (F=1.07, p > 0.05) biological CV intra of the specific catalytic cholinesterase activity (1.6%). Intra-individual variations of cholinesterase activity concentration in healthy individuals are therefore due to varying cholinesterase substance concentrations, and not to varying inhibition of the catalytic cholinesterase activity. The insignificant CV intra makes specific catalytic cholinesterase activity a rational quantity for evaluation of unexpected fluctuations of cholinesterase activity concentrations.
